Renoprotection by growth hormone-releasing hormone and agonists

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/27 (2006.01) A61P 39/00 (2006.01) G01N 33/50 (2006.01)

Patent

CA 2605036

In the present study, regulation of renal and pituitary GHRH-R mRNA levels was examined using in vivo models of NaCl or water homeostasis disruption. The presence of a unique GHRH/GHRH-R system in Henle's loop ascending thin limb cell and the specific regulation of GHRH-R mRNA levels and GHRH sensitivity in a situation of hyperosmotic stress, together with the strong effect of GHRH on mitochondrial and nuclear DNA repair/synthesis, indicate a role for GHRH in renoprotection. GHRH appears to be involved in adaptive processes related to DNA repair and/or synthesis thereby protecting ascending limb cell function in subjects with renal vulnerability (aging, diabetes) and were a health event could lead to a production of oxidative stress (antibiotic toxicity, cancer chemotherapeutic agent toxicity, infection, inflammation, ischemia ) and renal failure.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Renoprotection by growth hormone-releasing hormone and agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Renoprotection by growth hormone-releasing hormone and agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Renoprotection by growth hormone-releasing hormone and agonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1637142

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.